DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20193654

Seroprevalence and risk factors associated with anti-Toxoplasma gondii antibodies in pregnant women attending antenatal clinics in Benue state, Nigeria

Ifeoma N. Obijiaku, Jacob K.P. Kwaga, Junaidu Kabir, Idris A. Lawal, Damer P. Blake

Abstract


Background: Toxoplasmosis causes serious economic losses in livestock. Congenital transmission can occur in pregnant women, commonly with serious consequences.

Methods: A cross-sectional study was designed to screen for the absence or presence of anti-T. gondii IgM or IgG antibodies and explore associated risk factors in pregnant women (n=261) that attended antenatal clinics in selected hospitals in Benue state, Nigeria. Blood samples were subjected to enzyme linked immunosorbent assay (ELISA). Information on sociodemographic data and possible risk factors were obtained using a structured questionnaire.

Results: Out of 261 pregnant women, 19 (7.3%) and 108 (41.1%) were seropositive for anti-T. gondii IgM and IgG respectively. Comparison of IgM and IgG results suggested that 4.4% presented evidence of possible primary infection, 38.7% previous exposure, 2.8% possible reactivated or chronic infections and 51.8% were susceptible to T. gondii infection. The nature of women’s housing was significantly associated with anti-T. gondii IgM seropositivity (p <0.05). Pregnant women that lived in mud houses with thatched roofs were three times more likely to be seropositive than those who lived in concrete/brick houses with aluminium/zinc roofs (OR=3.123, 95% CI:1.027, 9.495). The study also showed that 17.7% of apparent infections were attributable to the nature of housing. More than half of the women sampled were at risk of contracting primary toxoplasmosis.

Conclusion: Screening for anti- T. gondii antibodies during antenatal care is advocated in order to detect affected women so that appropriate management strategies can be implemented.


Keywords


Benue state, Enzyme linked immunosorbent assay, Seroprevalence, Toxoplasma

Full Text:

PDF

References


Dubey JP. Toxoplasmosis of animals and humans. 2nd ed. Boca Raton, FL: CRC Press; 2010.

Centre for Disease control and Prevention. Toxoplasmosis (Toxoplasma infection). Available at www.cdc.gov/parasites/toxoplasmosis/biology.html Accessed 19 July 2019.

Robert-Gangneux F, Dardé ML. Epidemiology of and Diagnostic Strategies for Toxoplasmosis. Clin Microbiol Rev. 2012:25(2):264-96.

Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infants. Philadelphia: WB Saunders; 1990:89-195.

Hayde M, Pollak A. Clinical picture: neonatal signs and symptoms. In: P. Ambroise-Thomas and E. Petersen, eds. Congenital toxoplasmosis: scientific background, clinical management and control. France, Paris: Springer-Verlag; 2000:153-64.

Koskiniemi M, Lappalainen M, Toxoplasmosis needs evaluation: an overview and proposals. Am J Dis Child. 1989;143(6):724-8.

McLeod R, Boyer K. Management of and outcome for the newborn infant with congenital toxoplasmosis. In: Ambroise-Thomas P, Petersen E, eds. Congenital Toxoplasmosis: Scientific Background, Clinical Management and Control. Paris: Springer-Verlag; 2000:189-213.

Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 2005;15(5):66.

Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ. Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom. Epidemiol Infect. 2005;133(3):475-83.

Maggi P, Volpe A, Carito V, Schinaia N, Bino S, Basho M, et al. Surveillance of toxoplasmosis in pregnant women in Albania. New Microbiol. 2009;32(1):89-92.

Ramos JM, Milla A, Rodr´ıguez JC, Padilla S, Masi´a M, Guti´errez F. Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain. Parasitol Res. 2011;109(5):1447-52.

Lopes AP, Dubey JP, Moutinho O, Gargaté MJ, Vilares A, Rodrigues M, et al. Seroepidemiology of Toxoplasma gondii infection in women from the North of Portugal in their childbearing years. Epidemiol Infect. 2012;140(5):872-7.

Uysal A, Cüce M, Tañer CE, Uysal F, Atalay S, Göl B, et al. Prevalence of congenital toxoplasmosis among a series of Turkish women. Rev Med Chil. 2013;141(4):471-6.

Ayi I, Edu S, Apea-kubi K, Boamah D, Bosompem K, Edoh D. Sero-epidemiology of Toxoplasmosis amongst pregnant women in the greater Accra region of Ghana. Ghana Med J. 2010;43(3):107-14.

Bittencourt LHF, Lopes-Mori FMR, Mitsuka-Bregano R, Valentim-Zabott M, Freir RL, Pinto SB, et al. Seroepidemiology of toxoplasmosis in pregnant women since the implementation of the Surveillance Program of Toxoplasmosis Acquired in Pregnancy and Congenital in the western region of Parana, Brazil. Rev Bras Ginecol Obstet. 2012;34(2):63-8.

Monsalve-Castillo FM, Costa-Leon LA, Castellano ME, Suarez A, Atencio RJ. Prevalence of infectious agents in indigenous women of childbearing age in Venezuela. Biomedica. 2012;32(4):519-26.

Song K-J, Shin JC, Shin HJ, Nam HW. Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J Parasitol. 2005;43(2): 69-71.

Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol. 2012;19(3):365-7.

Bessieres MH, Berrebi A, Rolland M, Bloom MC, Roques C, Cassaing S, et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynec Reprod Biol. 2001;94(1):37-45.

Ishaku BS, Ajogi I, Umoh JU, Lawal I, Randawa AJ. Seroprevalence and Risk Factors for Toxoplasma gondii Infection among Antenatal Women in Zaria, Nigeria. Res J Medicine & Med Sci. 2009;4(2):483-8.

Deji-Agboola AM, Busari, OS, Osinupebi OA, Amoo AOJ. (2011). Seroprevalence of Toxoplasma gondii Antibodies among Pregnant Women Attending Antenatal Clinic of Federal Medical Center, Lagos, Nigeria. Int J Bio Med Res. 2011;2(4):1135-9.

Alayande MO, Edungbola LD, Fabiyi JP, Awosan KJ. Occurrence of antibody to Toxoplasma infection among pregnant women with obstetric histories and at different trimesters in Sokoto, Northwest Nigeria. Am J Res Commun. 2013;1:240-7.

Nasir IA, Aderinsayo AH, Mele HM, Aliyu MM. Prevalence and Associated Risk Factors of Toxoplasma gondii Antibodies among Pregnant Women Attending Maiduguri Teaching Hospital, Nigeria. J Med Sci. 2015;15(3):147-54.

Olusi TA, Salawu SA, Oniya MO. Seroepidemiology of Toxoplasmosis among Pregnant Women in Osogbo, Southwestern, Nigeria. J Infect Dis Immun. 2018;10(2):8-16.

Olusi TA, Gross U, Ajayi J. High prevalence of toxoplasmosis during pregnancy in Nigeria. Scand J Infect Dis. 1996;28(6):645-6.

Wikipedia. Benue State. Available at https://en.wikipedia.org/wiki/Benu%C3%A9_(state) Accessed 2 July 2019.

Amuta EU, Amali O, Jacob SE, Houmsou RS. Toxoplasma gondii IgG antibodies in HIV/AIDS patients attending hospitals in Makurdi metropolis, Benue state, Nigeria. Int J Med Biomed Res. 2012;1(3):186-92.

Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect. 2004;132:541-8.

Akhlaghi L, Ghasemi A, Hadighi R, Tabatabaie F. Study of seroprevalence and risk factors for Toxoplasma gondii among pregnant women in Karaj township of Alborz province. J Entomol Zool Stud. 2014;2(6):217-9.

Jula J, Girones G, Edao B, Deme C, Cebrian J, Butrón L, et al. Seroprevalence of Toxoplasma gondii infection in pregnant women attending antenatal care in southern Ethiopia. Rev Esp Quimioter. 2018;31(4):363-6.

Ibrahim HM, Mohamed AH, El-Sharaawy AA, El-Shqanqery HE. Molecular and serological prevalence of Toxoplasma gondii in pregnant women and sheep in Egypt. Asian Pac J Trop Med. 2017;10(10):996-1001.

Porto AMF, de Amorim MMR, Coelho ICN, Santos LC. Serologic profile of toxoplasmosis in pregnant women attended at a teaching-hospital in Recife. Revista Assoc Med Bras. 2008;54(3):242-8.

Castro AT, Gongora A, Gonzalez ME. Toxoplasma gondii antibody seroprevalence in pregnant women from Villavicencio, Colombia. Orinoquia. 2009;12: 91-100.

Messerer L, Bouzbid S, Gourbdji E, Mansouri R, Bachi F. (2014) Seroprevalence of toxoplasmosis in pregnant women in nnaba, Algeria. Rev Epidemiol Sante Publique. 2014;62:160-5.

Paul E, Kiwelu I, Mmbaga B, Nazareth R, Sabuni E, Maro A, et al. Toxoplasma gondii seroprevalence among pregnant women attending antenatal clinic in Northern Tanzania. Trop Med Health. 2018;46(1): 39.

Katz M, Despommier DD, Gwadz RW. Parasitic Diseases. New York: Springer Science & Business Media; 2012:162.

Zemene E, Yewhalaw D, Abera S, Belay T, Samuel A, Zeynudin AJ. Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia. BMC Infect Dis, 2012;12(1):337.

Obijiaku IN, Ornguga N, Adikwu AA. Seroprevalence of Toxoplasma gondii infection in slaughtered pigs in Makurdi, Nigeria. Sokoto J of Vet Scis. 2017;15(3):91-4.

Ishaku BS, Abdullahi M, Nalong D, Jonah R, Mayowa O. Seroprevalence and risk factors for Toxoplasma gondii in pigs, sheep and goats at slaughter in Jos municipal abattoir, Nigeria. Vet Scie Res Review. 2018;4(2):55-61.

Al-Qurashi AR, Ghandour AM, Obeid OE, Al-Mulhim A, Makki SM. Seroepidemiological study of Toxoplasma gondii infection in the human population in the Eastern region. Saudi Med J. 2001;22:13-8.